📰 Given Sera Prognostic News
Given Sera Prognostic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Sera Prognostic. Real-time updates on events, politics, business and more.
September 5, 2023
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) and Sera Prognostics (NASDAQ:SERA – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, institutional ownership and profitability. Profitability This table compares BioNexus Gene […]
September 5, 2023
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) and Sera Prognostics (NASDAQ:SERA – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk and institutional ownership. Profitability This table compares BioNexus Gene […]
September 1, 2023
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) and Sera Prognostics (NASDAQ:SERA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, institutional ownership and valuation. Profitability This table compares BioNexus Gene […]
July 30, 2023
Sera Prognostics (NASDAQ:SERA – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability. Valuation & Earnings This table compares Sera […]
July 28, 2023
Sera Prognostics (NASDAQ:SERA – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability. Analyst Ratings This is a summary of […]
July 21, 2023
Sera Prognostics (NASDAQ:SERA – Get Free Report) and Sonic Healthcare (OTCMKTS:SKHCF – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, earnings and institutional ownership. Institutional & Insider Ownership 29.4% of Sera Prognostics […]
July 21, 2023
Sonic Healthcare (OTCMKTS:SKHCF – Get Free Report) and Sera Prognostics (NASDAQ:SERA – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends. Institutional and Insider Ownership 31.8% of Sonic Healthcare […]
June 11, 2022
Sera Prognostics (NASDAQ:SERA – Get Rating) and Celcuity (NASDAQ:CELC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership. Analyst Ratings This is a summary of recent recommendations and […]
June 11, 2022
Sera Prognostics (NASDAQ:SERA – Get Rating) and Celcuity (NASDAQ:CELC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Insider & Institutional Ownership 63.2% of Sera Prognostics shares are […]
June 10, 2022
Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it contrast to its peers? We will compare Sera Prognostics to related companies based on the strength of its valuation, earnings, profitability, dividends, institutional ownership, risk and analyst recommendations. Insider and Institutional Ownership 63.2% of […]